Compensated Awareness Post View
Disclaimer
Placement of CASMED’s (CASM) FORE-SIGHT Cerebral Oximeter Reaches 1,000
Noninvasive patient monitoring medical devices leader CAS Medical Systems, Inc. (CASMED) announced the global cumulative net shipment total for its FORE-SIGHT Cerebral Oximeters reached 1,000 last week. The total includes monitors installed at nine of the top 20 cardiac surgery centers in United States and three of the country’s top 10 pediatric centers. CASMED previously announced a net cumulative total of 935 units as of Dec. 31, 2013.
Achieving this milestone denotes the continued market acceptance strength of the FORE-SIGHT ELITE monitor, which CASMED introduced in September 2013. The cumulative sales of the company’s disposable oximetry sensors has surpassed 300,000, meaning more than 150,000 patients – adults, children, and newborns – have benefited from FORE-SIGHT technology.
“Improving patient care is one of CASMED’s core values,” said CASMED President and CEO Tom Patton, “and it is rewarding to know that with FORE-SIGHT oximetry we have enabled clinicians around the world to provide better outcomes for so many people.”
CASMED recently added four U.S. direct sales representatives to its team in response to growing demand for the company’s products and increasing interest in cerebral oximetry. The new representatives will handle territories that have previously been under-represented by independent distributors. This brings CASMED’s U.S. distribution team to nine direct reps and three manufacturer’s rep organizations.
For more information, visit www.casmed.com
